Brief: Compugen and Bristol-Myers Squibb Terminate Master Trial Collaboration Agreement

Compugen

04/08/2022 12:55

Aug 4 (Reuters) - Compugen Ltd  CGEN.TA :
    * COMPUGEN - ON AUG 3, CO, BRISTOL-MYERS SQUIBB ENTERED
LETTER
AGREEMENT THROUGH WHICH MASTER TRIAL COLLABORATION AGREEMENT
BETWEEN PARTIES IS TERMINATED
    * COMPUGEN - TERMINATION INCLUDES TERMINATION OF THE RIGHT
OF
FIRST NEGOTIATION AND THE EXCLUSIVITY RIGHT GRANTED TO BMS
THEREUNDER

Further company coverage:  CGEN.TA 

 ((Reuters.Briefs@thomsonreuters.com;))